CMC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, and River Vision Development Corporation (River Vision), a private company focused on ophthalmology, ...
Discussion to Cover the Importance of Early-Stage CMC Testing in Enhancing Biologic Predictability, Scaling Up, and Accelerating Time to Market KAISERAUGST, Switzerland, April 22, 2025 /PRNewswire/ -- ...
Recognized as Biologics CDMO of the Year, BioDlink shares insights into the world's first approved EGFR-targeted ADC for recurrent/metastatic nasopharyngeal carcinoma The company enables seamless ...
Enhancements enable pharma, biotech and generics companies to streamline regulatory tracking and optimize life cycle management for small molecules and biologics CMC activities account for nearly 18% ...
* Portola Pharmaceuticals- pursuant to agreement, cmc will provide other services supporting co's regulatory applications in United States, European Union * Portola Pharmaceuticals Inc- under ...
Dr. Olga Paley, Director of Bioprocess Development at Takeda, will discuss “Advancing Takeda’s Bioprocessing Platforms in Support of Clinical and Commercial Drug Supply” about the Chemistry, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results